INDICATIONS of ADEL 19 (LASSITUL)
For exhaustion (mental and physical); depression; weakness; loss of appetite and loss of self confidence.
INGREDIENTS of ADEL 19 (LASSITUL)
Agaricus muscarius 6X, Alfalfa 1X, China officinalis 3X, Ginseng 4X, Lycopodium 6X, Piper methysticum 8X, Staphisagria 10X. Agaricus muscarius?strengthens the secretion of all glands, and over this the work of the cholbladder and pancreas. All gastrocardial troubles will be regulated and in this connection the nerves troubles are included. Alfalfa?stands for digestion troubles too, regulates bad nerves states. It is a named matter for weakness of the nerves, sleeplessness and no appetite situations. China officinalis?is a reliable, well known matter for unusual weak persons and has a good relationship to the middle organs, stimulating the work of the liver, choler and spleen. Over this it is a well reputated remedy for fever states and irritated nerves. Ginseng?shows all symptoms of exhaustion too and stands against sexual weakness of men, mostly in combination with marked rheumatic states. Lycopodium?is a old and well tried remedy. You can find several persons poisoned with their own metabolic rest loadings and so they seem to be pale anxies in the mood, angry and irritated persons, weak in the body and with bad smelling around. Piper methysticum?is a very effective medicine for mental bad states, it harmonizes but doesn’t calm to become tired. It regulates disturbances of the stomach and other digestive troubles of a person. Staphisagria is?the remarkable ingredient in this complex and for nervous irritations with colics and great neurasthenia states, neuralgic sensations and troubles in the warming regulation. All this parts help to overcome a lassitude state.
RECOMMENDED DOSAGE (Unless otherwise prescribed)
Adults – 15-20 drops, 3 times a day in 1/4 Cup of water.
Terms and Conditions
Homeopathic products have several uses and should be taken on the basis of symptom similarity. Results may vary depending upon the conditions.
There are no reviews yet.